While cancer is deadly it's relatively rare compared to other medical conditions. An actual cure would be ridiculously valuable but you ultimately still have a limit to the amount of patients you can treat which obviously limits the amount of money to be made. There is a reason the FDA has orphan designation and fast track designation. There needs to be some incentive for companies to to develop therapies for these rarer diseases.
News 
Market Data 
Discover 
